| mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |